The stimulation of human blood with a Ca2+ ionophore, A23187, leads to activation of polymorphonuclear leucocytes (PMN) with release of small amounts of catalyticaly active elastase, as demonstrated by the formation of a characteristic product, the N-terminal A alpha (1-21) peptide of the Aa subunit of fibrinogen. The identity of the peptide was initially established by radioimmunoassay (r.i.a.) with an antibody raised to A alpha (1-21). We now provide independent confirmation of the formation of A alpha (1-21) by fast-atom-bombardment-m.s. analysis of the fractions separated chromatographically after spiking of plasma samples with peptide labelled with [2H8]Phe at position 8. Identity of the peptides was established on the basis of their chromatographic retention time and by the distinct peaks in the mass spectra of these fractions. The relative intensities of the molecular ions of natural and labelled peptides were measured. On the basis of a comparison of the peaks of similar intensities, the concentration of the natural peptide at the time of spiking was close (79%) to the amount obtained by r.i.a. An additional peptide, des-alanyl-A alpha (2-21), was also seen. The total amount of material measured by r.i.a. could be accounted for by the sum of these two provides. The addition of label and assay by m.s. has provided an independent physical-chemical method for identifying A alpha (1-21) as a characteristic product of PMN elastase release in whole blood, but which is absent in freshly drawn blood.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
January 1992
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Research Article|
January 15 1992
Purification and characterization by fast-atom-bombardment mass spectrometry of the polymorphonuclear-leucocyte-elastase-generated Aα (1–21) fragment of fibrinogen from human blood after incubation with calcium ionophore A23187
R S Dewey;
R S Dewey
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
J M Liesch;
J M Liesch
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
H R Williams;
H R Williams
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
E E Sugg;
E E Sugg
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
C A Dolan;
C A Dolan
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
P Davies;
P Davies
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
R A Mumford;
R A Mumford
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
G Albers-Schönberg
G Albers-Schönberg
*Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065, U.S.A.
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© 1992 The Biochemical Society, London
1992
Biochem J (1992) 281 (2): 519–524.
Citation
R S Dewey, J M Liesch, H R Williams, E E Sugg, C A Dolan, P Davies, R A Mumford, G Albers-Schönberg; Purification and characterization by fast-atom-bombardment mass spectrometry of the polymorphonuclear-leucocyte-elastase-generated Aα (1–21) fragment of fibrinogen from human blood after incubation with calcium ionophore A23187. Biochem J 15 January 1992; 281 (2): 519–524. doi: https://doi.org/10.1042/bj2810519
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |